Arch. Dis. Child

HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS REGISTER
[Advanced]

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this link to a friend
Right arrow Similar articles in ADC Online
Right arrow Similar articles in PubMed
Right arrow Add article to my folders
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Pereira, S P
Right arrow Articles by Mieli-Vergani, G
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Pereira, S P
Right arrow Articles by Mieli-Vergani, G
Topic Collections
Right arrowRelevant Article
Archives of Disease in Childhood Fetal and Neonatal Edition 2003;88:F113
© 2003 Archives of Disease in Childhood Fetal and Neonatal Edition


ORIGINAL ARTICLE

Intestinal absorption of mixed micellar phylloquinone (vitamin K1) is unreliable in infants with conjugated hyperbilirubinaemia: implications for oral prophylaxis of vitamin K deficiency bleeding

S P Pereira1, M J Shearer2, R Williams3, G Mieli-Vergani4

1 Department of Gastroenterology, The Middlesex Hospital, University College London Hospitals NHS Trust, London, UK
2 Vitamin K Research and Diagnostic Units, The Haemophilia Centre, St Thomas’ Hospital, London, UK
3 Institute of Hepatology, University College London, UK
4 Paediatric Liver Service, King’s College Hospital, London, UK

Correspondence to:
Correspondence to:
Dr Pereira, Department of Gastroenterology, The Middlesex Hospital, University College London Hospitals NHS Trust, Mortimer Street, London W1N 8AA, UK;
steve.pereira{at}uclh.org

Objective: To compare the pharmacokinetics and efficacy of oral versus intravenous mixed micellar vitamin K prophylaxis in infants with cholestatic liver disease, a known risk factor for vitamin K deficiency bleeding.

Design: Prospective randomised controlled study.

Setting: Paediatric Liver Unit.

Patients: Forty four infants less than 6 months of age with conjugated hyperbilirubinaemia.

Main outcome measures: Serum concentrations of vitamin K1 and undercarboxylated prothrombin (PIVKA-II; a sensitive functional indicator of vitamin K status) before and for up to four days after a single dose of mixed micellar K1 1 mg intravenously or 2 mg orally. Comparison of K1 levels 24 hours after oral K1 with those from 14 healthy newborns given the same dose.

Results: At admission, 18 infants (41%) had elevated levels of serum PIVKA-II and eight (18%) had low K1 concentrations, indicative of subclinical vitamin K deficiency. Median serum K1 concentrations were similar in the oral and intravenous groups at baseline (0.92 v 1.15 ng/ml), rising to 139 ng/ml six hours after intravenous K1 but to only 1.4 ng/ml after oral administration. In the latter group, the low median value (0.95 ng/ml) and wide range (< 0.15–111 ng/ml) of serum K1 compared unfavourably with the much higher levels (median 77, range 11–263 ng/ml) observed in healthy infants given the same oral dose, and suggested impaired and erratic intestinal absorption in cholestatic infants. The severity of malabsorption was such that only 4/24 (17%) achieved an incremental rise in serum K1 > 10 ng/ml.

Conclusions: The intestinal absorption of mixed micellar K1 is unreliable in infants with conjugated hyperbilirubinaemia. Given the strong association between cholestasis and late vitamin K deficiency bleeding, these data provide an explanation for the failure of some oral vitamin K1 prophylaxis regimens in infants with latent cholestasis.


Keywords: vitamin K; hyperbilirubinaemia; cholestasis; liver

Abbreviations: INR, international normalised (prothrombin) ratio; PIVKA, proteins induced by vitamin K absence or antagonism; VKDB, vitamin K deficiency bleeding


Relevant Article

Fantoms
Ben Stenson
Arch. Dis. Child. Fetal Neonatal Ed. 2003 88: F80. [Extract] [Full Text] [PDF]



This article has been cited by other articles:


Home page
PediatricsHome page
P. M. van Hasselt, T. J. de Koning, N. Kvist, E. de Vries, C. R. Lundin, R. Berger, J. L. L. Kimpen, R. H. J. Houwen, M. H. Jorgensen, H. J. Verkade, et al.
Prevention of Vitamin K Deficiency Bleeding in Breastfed Infants: Lessons From the Dutch and Danish Biliary Atresia Registries
Pediatrics, April 1, 2008; 121(4): e857 - e863.
[Abstract] [Full Text] [PDF]


Home page
Arch. Dis. Child.Home page
P. Clarke and M. J Shearer
Vitamin K deficiency bleeding: the readiness is all
Arch. Dis. Child., September 1, 2007; 92(9): 741 - 743.
[Full Text] [PDF]


Home page
Arch. Dis. Child. Fetal Neonatal Ed.Home page
E Hey
Vitamin K--what, why, and when
Arch. Dis. Child. Fetal Neonatal Ed., March 1, 2003; 88(2): F80 - F83.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS REGISTER
ARCH DIS CHILD FETAL NEONATAL ED ED PRACTICE
Terms and conditions relating to subscriptions purchased online  ¦  Website terms and conditions  ¦  Privacy policy
Copyright © 2003 BMJ Publishing Group Ltd & Royal College of Paediatrics and Child Health